Rello, Jordi
,
Ramírez-Estrada, Sergio
Romero, Anabel
Arvaniti, Kostoula
Koulenti, Despoina
Nseir, Saad
Oztoprak, Nefise
Bouadma, Lila
Vidaur, Loreto
Lagunes, Leonel
Peña-López, Yolanda
Funding for this research was provided by:
CIBERES (06/06/036)
European Society of Clinical Microbiology and Infectious Diseases
Article History
Received: 27 March 2019
Accepted: 17 May 2019
First Online: 24 June 2019
Compliance with ethical standards
:
: Dr. Rello has served on the speakers’ bureau and as a consultant for Cubist, Bayer, ROCHE, Medimmune, Pfizer, Anchoagen, and Aridis. The other authors report no conflicts of interest relevant to this article.
: The study protocol was approved by the institutional review board on human research at each participating center and at Vall d’Hebron Barcelona Hospital Campus, the coordinating center [PR(AG)25/2014]. Patients (or the relatives of unconscious patients) were asked to provide written consent prior to participation in the study.